Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-16
2005-08-16
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C435S069100, C435S069400, C514S814000, C530S395000, C530S333000, C930S010000, C930S090000
Reexamination Certificate
active
06930086
ABSTRACT:
This invention is directed to an erythropoietin mutein having in vivo biological activity for causing bone marrow cells to increase production of reticulocytes and red blood cells, in that the mutein is N-glycosylated at Asn38 and Asn83 but not N-glycosylated at Asn24. Such muteins have improved pharmaceutical properties.
REFERENCES:
patent: 0 409 113 (1991-01-01), None
patent: 0 410 246 (1991-01-01), None
patent: 411 678 (1991-02-01), None
patent: 640 619 (1995-03-01), None
patent: WO 97/09996 (1997-03-01), None
patent: WO 00 32772 (2000-06-01), None
patent: WO 01/02017 (2001-01-01), None
Felix et al., ACS Symp. Ser. 680, pp. 218-238 (1997).
Broudy et al., Arch. Biochem. Biophys., 265, pp. 329-336 (1988).
Lai et al., J. Biol. Chem., 261, pp. 3116-3121 (1986).
Nimtz et al., Eur. J. Biochem, 213, pp. 39-56 (1993).
Sasaki et al., Biochemistry, 27, pp. 8618-8626 (1988).
Delorme et al., Biochemistry, 31, pp. 9871-9876 (1992).
Fibi et al., Blood, 85, pp. 1229-1236 (1995).
Veronese, Biomaterials, 22, pp. 405-417 (2001).
Cointe Didier, et al., Glycobiology, vol. 10, No. 5, pp. 511-519 (2000).
Yamaguchi, K., et al., Journal of Biological Chemistry, American Society of Biological Chemists, Baltimore, MD, vol. 266, No. 30, pp. 20434-20439 (1991).
Dube, S., et al., Journal of Biological Chemistry, Society of Biological Chemists, Baltimore, MD, vol. 263, No. 33, pp. 17516-17521 (1988).
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Schnizer Holly
Weber Jon
LandOfFree
Diglycosylated erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diglycosylated erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diglycosylated erythropoietin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3499283